Literature DB >> 29417948

Different network pharmacology mechanisms of Danshen-based Fangjis in the treatment of stable angina.

Guo-Xia Zhang1, Ying-Ying Zhang2,3, Xiao-Xu Zhang4, Peng-Qian Wang5, Jun Liu3, Qiong Liu3, Zhong Wang3.   

Abstract

Danshen (Salvia miltiorrhiza) preparations such as Danhong injection, Danshen injection, Salvianolate injection, compound Danshen injection and Sodium Tanshinone IIA Sulfonate (STS) injection are widely used in China to treat stable angina (angina pectoris) caused by coronary heart disease. In this study we compared the network pharmacological mechanisms of the 5 Danshen preparations. Following a literature search performed in PubMed, EMBASE, Cochrane Library, China National Knowledge Infrastructure (CNKI) database, China Biology Medicine (CBM) database, China Conference Paper Database, Wanfang Database, VIP Database and Conference Proceedings Citation Index (through January 2015), 444 randomized controlled trial publications detailing the use of the 5 Danshen-based injections for treating stable angina were identified, and their combined data were analyzed using a network meta-analysis. All of the 5 Danshen-based preparations were effective in treating stable angina with clinical improvement rates of 72.4%-91.6% and electrocardiogram (ECG) improvement rates of 54.5%-71.6%. According to both clinical improvement and ECG improvement, the 5 Danshen-based preparations were ranked as follows: Danhong injection > Salvianolate injection > STS injection > compound Danshen injection > Danshen injection. There were no significant differences among the safety profiles of the 5 Danshen preparations. The meta-analysis results were further examined using a network pharmacology approach and functional enrichment analysis, which revealed that Danshen and Danhong injections affected 4 and 15 signaling pathways, respectively, and that the 4 signaling pathways affected by Danshen were a subset of those influenced by Danhong. Therefore, Danhong injection affected some unique signaling pathways that might regulate lipoprotein metabolism, oxidation, and inflammation, and protect vascular endothelia, reflecting the multi-component and multi-target characteristics of this traditional formula and its strengths in treating complex diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29417948      PMCID: PMC6256275          DOI: 10.1038/aps.2017.191

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  12 in total

1.  CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2010-03-25       Impact factor: 6.437

2.  Confirming an integrated pathology of diabetes and its complications by molecular biomarker-target network analysis.

Authors:  Zide Zhao; Yingying Zhang; Fengchun Gai; Ying Wang
Journal:  Mol Med Rep       Date:  2016-07-07       Impact factor: 2.952

3.  Convergent and divergent pathways decoding hierarchical additive mechanisms in treating cerebral ischemia-reperfusion injury.

Authors:  Ying-Ying Zhang; Hai-Xia Li; Yin-Ying Chen; Hong Fang; Ya-Nan Yu; Jun Liu; Zhi-Wei Jing; Zhong Wang; Yong-Yan Wang
Journal:  CNS Neurosci Ther       Date:  2013-12-19       Impact factor: 5.243

4.  No increased risk of coronary heart disease for patients receiving androgen deprivation therapy for prostate cancer in Chinese/Taiwanese men.

Authors:  L H Wang; C K Liu; C H Chen; L T Kao; H C Lin; C Y Huang
Journal:  Andrology       Date:  2015-12-29       Impact factor: 3.842

5.  Cardiomyocyte apoptosis with enhanced expression of P53 and Bax in right ventricle after pulmonary arterial banding.

Authors:  S Ikeda; M Hamada; K Hiwada
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

6.  Increased p53 protein expression in human failing myocardium.

Authors:  H Song; J V Conte; A H Foster; J S McLaughlin; C Wei
Journal:  J Heart Lung Transplant       Date:  1999-08       Impact factor: 10.247

7.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

8.  [Comparative study of T cell proliferative response in different types of coronary heart diseases].

Authors:  Hua Zheng; Sai-zhu Wu; Wen-yan Lai
Journal:  Di Yi Jun Yi Da Xue Xue Bao       Date:  2004-04

9.  Drug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart disease.

Authors:  Yong Wang; Zhongyang Liu; Chun Li; Dong Li; Yulin Ouyang; Junda Yu; Shuzhen Guo; Fuchu He; Wei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-08       Impact factor: 2.629

Review 10.  Salvia miltiorrhiza Roots against Cardiovascular Disease: Consideration of Herb-Drug Interactions.

Authors:  Feng Chen; Li Li; Dan-Dan Tian
Journal:  Biomed Res Int       Date:  2017-04-03       Impact factor: 3.411

View more
  11 in total

1.  New omic and network paradigms for deep understanding of therapeutic mechanisms for Fangji of traditional Chinese medicine.

Authors:  Dayue Darrel Duan; Zhong Wang; Yong-Yan Wang
Journal:  Acta Pharmacol Sin       Date:  2018-06       Impact factor: 6.150

2.  Effects of salvianolate on microcirculatory disturbance in patients with stable coronary heart disease: study protocol for a randomized controlled trial.

Authors:  Zhanlu Li; Yi Luan; Min Wang; Ya Li; Xiaohua Shen; Guosheng Fu; Wenbin Zhang
Journal:  Trials       Date:  2021-03-08       Impact factor: 2.279

Review 3.  A scoping review of network meta-analyses assessing the efficacy and safety of complementary and alternative medicine interventions.

Authors:  Misty Pratt; Susan Wieland; Nadera Ahmadzai; Claire Butler; Dianna Wolfe; Kusala Pussagoda; Becky Skidmore; Argie Veroniki; Patricia Rios; Andrea C Tricco; Brian Hutton
Journal:  Syst Rev       Date:  2020-04-30

4.  Systematic Elucidation of the Mechanism of Genistein against Pulmonary Hypertension via Network Pharmacology Approach.

Authors:  Yucai Chen; Di Chen; Sijia Liu; Tianyi Yuan; Jian Guo; Lianhua Fang; Guanhua Du
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

5.  Investigating the protective effect of tanshinone IIA against chondrocyte dedifferentiation: a combined molecular biology and network pharmacology approach.

Authors:  Yushen Zhang; Liguo Sun; Xincheng Liu; Dongze Zhu; Jingyi Dang; Yingsen Xue; Hongbin Fan
Journal:  Ann Transl Med       Date:  2021-02

6.  A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS-CoV-2.

Authors:  Lilian Peñalver; Philipp Schmid; Dávid Szamosvári; Stefan Schildknecht; Christoph Globisch; Kevin Sawade; Christine Peter; Thomas Böttcher
Journal:  Angew Chem Int Ed Engl       Date:  2021-01-28       Impact factor: 15.336

7.  Pharmacological Mechanisms Underlying the Anti-asthmatic Effects of Modified Guomin Decoction Determined by Network Pharmacology and Molecular Docking.

Authors:  Guishu Wang; Bo Zhou; Zheyi Wang; Yufeng Meng; Yaqian Liu; Xiaoqin Yao; Cuiling Feng
Journal:  Front Mol Biosci       Date:  2021-04-22

8.  Effects and Mechanism of Oxymatrine Combined with Compound Yinchen Granules on the Apoptosis of Hepatocytes through the Akt/FoxO3a/Bim Pathway.

Authors:  Xian Zhang; Jiajia Ge; Xuejuan Zhu; Haifeng Zhang; Yuanzi Wang; Tongtong Xu; Wei Jiang; Bin Zhang
Journal:  Biomed Res Int       Date:  2022-01-06       Impact factor: 3.411

9.  Integrated Pharmacogenetics Analysis of the Three Fangjis Decoctions for Treating Arrhythmias Based on Molecular Network Patterns.

Authors:  Penglu Wei; Dehuai Long; Yupei Tan; Wenlong Xing; Xiang Li; Kuo Yang; Hongxu Liu
Journal:  Front Cardiovasc Med       Date:  2021-12-24

10.  Pharmacological Effects of Agastache rugosa against Gastritis Using a Network Pharmacology Approach.

Authors:  Hyeon-Hwa Nam; Joong Sun Kim; Jun Lee; Young Hye Seo; Hyo Seon Kim; Seung Mok Ryu; Goya Choi; Byeong Cheol Moon; A Yeong Lee
Journal:  Biomolecules       Date:  2020-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.